SRRK vs STOK Stock Comparison

STOK currently leads SRRK in this stock comparison, with AIQ scores of 42 vs 39. The clearest difference is quality, while SRRK has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 3 points
SRRK
Healthcare
vs
STOK
Healthcare
SRRK
Scholar Rock Holding Corporation
Price
$43.21
Day move
+0.1%
AIQ Score
39/100
Best edge
Momentum
Sector
Healthcare
STOK
Stoke Therapeutics, Inc.
Leads
Price
$26.68
Day move
+1.83%
AIQ Score
42/100
Best edge
Quality
Sector
Healthcare

What is the main difference between SRRK and STOK?

STOK leads the current stock comparison as Stoke Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Scholar Rock Holding Corporation vs Stoke Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

STOK leads

STOK leads by 3 AIQ points, primarily on Quality and Risk Resilience, having only recently taken the lead back from SRRK. Wall Street currently favors SRRK on target upside.

Fragile: 3 of 5 evidence groups support STOK, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Reversed
SRRK

Scholar Rock Holding Corporation

AIQ Score
39/100
AIQ Edge Score
6/10
STOK

Stoke Therapeutics, Inc.

Leads
AIQ Score
42/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors STOK over SRRK, 42 versus 39 as of Nov 15, 2026. STOK's advantage is driven primarily by stronger quality and risk resilience, while SRRK holds the stronger momentum profile. STOK also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors SRRK. 3 of 5 covered evidence groups favor STOK today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. STOK lead: Reversed — SRRK led by 3 AIQ points 30 sessions ago; STOK now leads by 3.

Compare Scholar Rock Holding Corporation and Stoke Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

SRRK
+25.8%
STOK
-5.4%

Price return comparison

Growth of $10,000, price only

SRRK $12,582 · STOK $9,461

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare SRRK and STOK against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

SRRK advantage
0
STOK advantage
  • Quality14 vs 42
    STOK +28
  • Momentum54 vs 47
    SRRK +7
  • Risk Resilience52 vs 59
    STOK +7

3 of 5 evidence groups favor STOK. STOK’s edge is concentrated in quality and risk resilience; SRRK keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

SRRK+1 AIQ

Largest factor move: Momentum +1

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.39x)
STOK0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon

STOK's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — SRRK and STOK both carry a full feed there.

The central trade-off

STOK (Stoke Therapeutics, Inc.): the stronger current systematic profile, led by quality and risk resilience.

SRRK (Scholar Rock Holding Corporation): the counter-case, on momentum, analyst expectations — but at materially higher volatility, 62.2% against 48.9%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

STOK

STOK on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

Even

The two are level on Value.

Momentum

SRRK

SRRK on the Momentum factor, by 7 points.

Lower downside

STOK

STOK on Risk Resilience, by 7 points.

Analyst upside

SRRK

SRRK on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors STOK, analyst targets favor SRRK. That disagreement is the most useful thing on this page.

MeasureSRRKSTOKNote
Implied upside to target+65%+61.2%SRRK has more room
Target dispersion+36.5%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1914Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor STOK. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven39 vs 42
FundamentalsSTOKon balanceEPS growth 3.6% vs -16.1%; TTM ROE -63.6% vs -20.9%; gross margin -82.4% vs 88.5%; operating margin -717.3% vs -9.1% — STOK takes 3 of 4 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsSTOKPrice vs 50-day -6.3% vs 0.9%; vs 200-day -10.4% vs -13.3%
Risk ResilienceSTOKRisk Resilience 52 vs 59
Analyst expectationsSRRKTarget upside 65% vs 61.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of SRRK and STOK and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on STOK.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

STOK lead: Reversed — SRRK led by 3 AIQ points 30 sessions ago; STOK now leads by 3.

May 27SRRK leads above the line · STOK leads belowNov 13
Today
STOK +3
39 vs 42
7 sessions ago
SRRK +5
45 vs 40
30 sessions ago
SRRK +3
39 vs 36
90 sessions ago
SRRK +5
49 vs 44

The lead changed hands once in this window, most recently on Nov 11 when STOK moved ahead of SRRK.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

SRRK

0 bullish / 3 bearish / 1 neutral

Only SRRK

  • Downtrend Structure Active — bearish, trend, long horizon
STOKConflicted

3 bullish / 2 bearish / 2 neutral, conflicted

Only STOK

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 3 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode, Low Volume Rally Warning.

STOK leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

SRRKConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.1%, AIQ +1 points).

STOKNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.83%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1SRRK closes the Quality gap — currently 28 points behind, the largest single contributor to STOK's edge.
  2. 2SRRK's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3STOK's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

STOK leads on balance
MetricSRRKSTOK
Revenue growth (YoY)0%20.7%
EPS growth (YoY)3.6%-16.1%
Gross margin-82.4%88.5%
Operating margin-717.3%-9.1%
Return on equity (TTM)-63.6%-20.9%
Debt to equity1.20

Performance

STOK leads 4 of 6 windows
MetricSRRKSTOK
1 week (5 sessions)-8%0.5%
1 month (20 sessions)8.3%10.4%
3 months (63 sessions)-17%-17%
6 months (126 sessions)-12.5%-11.3%
Year to date-1.9%-15.9%
1 year (252 sessions)40.2%6.2%

Technicals

STOK has the stronger structure
MetricSRRKSTOK
RSI (14)45.351.3
ADX (14)26.217.3
Price vs 50-day-6.3%0.9%
Price vs 200-day-10.4%-13.3%
Volatility (1M, annualized)62.2%48.9%

Risk

STOK is the more resilient
MetricSRRKSTOK
Beta1.120.96
Sharpe ratio0.840.23
Sortino ratio1.490.35
Max drawdown-34%-41.3%
Current drawdown-28%-30.4%
Annualized volatility57.4%53.2%
Value at risk (95%)-4.5%-5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, SRRK or STOK?

On the Algovestiq AIQ Score, STOK is the stronger of the two as of Nov 15, 2026, scoring 42 against SRRK's 39. The edge comes from quality and risk resilience. SRRK is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is SRRK or STOK the better buy right now?

STOK carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.

Why does the AIQ Score favor STOK over SRRK?

The composite weights Quality, Value, Momentum and Risk Resilience. STOK leads Quality by 28 points; SRRK leads Momentum by 7 points; STOK leads Risk Resilience by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, SRRK or STOK?

Analyst price targets imply +65% upside for SRRK and +61.2% for STOK, so the Street currently favors SRRK. That points the opposite way to the AIQ Score, which favors STOK. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, SRRK or STOK?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, SRRK or STOK?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, SRRK or STOK?

SRRK on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, SRRK or STOK?

STOK is the more resilient of the two, so the other name carries the higher downside risk. STOK on Risk Resilience, by 7 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is SRRK more profitable than STOK?

STOK leads on the comparable margin measures — gross margin -82.4% vs 88.5%; operating margin -717.3% vs -9.1%; ttm roe -63.6% vs -20.9%.

Is STOK's lead over SRRK getting stronger or weaker?

STOK lead: Reversed — SRRK led by 3 AIQ points 30 sessions ago; STOK now leads by 3. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-11-11, when STOK moved ahead of SRRK.

What would change the SRRK vs STOK verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: SRRK closes the Quality gap — currently 28 points behind, the largest single contributor to STOK's edge; SRRK's Death Cross Active resolves — a bearish trend rule currently active against it; STOK's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about SRRK and STOK?

SRRK: 0 bullish / 3 bearish / 1 neutral. STOK: 3 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on SRRK is Death Cross Active (bearish, long horizon). On STOK it is Death Cross Active (bearish, long horizon).

Compare SRRK and STOK with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.